(Total Views: 345)
Posted On: 03/16/2020 4:28:18 PM
Post# of 11803
True, but most companies that are under consideration from the FDA would be newsworthy.
DECN needs someone other than Mr. Berman. Someone who knows more about more. A stock trader for example. Or perhaps someone who attends conferences also attended by Roche. Step right up.
DECN needs someone other than Mr. Berman. Someone who knows more about more. A stock trader for example. Or perhaps someone who attends conferences also attended by Roche. Step right up.
(0)
(0)
